logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yunjiang Liu

Hebei Provincial Key Laboratory of Tumor Microenvironment and Drug Resistance
H指数:20
被引数:1,665

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pyrotinib plus epirubicin and cyclophosphamide followed by docetaxel and trastuzumab as neoadjuvant therapy for HER2-positive early breast cancer: A multicenter non-randomized phase II study

吡咯替尼联合表柔比星和环磷酰胺序贯多西他赛和曲妥珠单抗作为HER2阳性早期乳腺癌的新辅助治疗：一项多中心非随机II期研究

BMC Medicine
IF8.3
2026-08-310
OA
Xiangmei Zhang; Li Wang; Shang Wu; Haifeng Cai; Ruixue Huang; Li Liu; Chengxu Xiao; Chao Shi; Ruizhen Luo; Xianqiao Li; Meng Han; Yunjiang Liu
Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial

新型CDK2/4/6抑制剂culmerciclib (TQB3616) 联合氟维司群治疗HR阳性HER2-negative晚期乳腺癌: 一项随机、双盲、3期临床试验

Signal Transduction and Targeted Therapy
IF52.7
2025-12-180
OAAI
Yongmei Yin; Qingyuan Zhang; Tao Sun; Chunfang Hao; Zhihong Wang; Jin Yang; Yongsheng Wang; Yanxia Shi; Jing Sun; Quchang Ouyang; Haichuan Su; Jinsheng Wu; Lu Gan; Meng Han; Liming Gao; Xiaojia Wang; Bing Zhao; Hui Li; Jiuda Zhao; Hongwei Yang; Fangling Ning; Fuguo Tian; Juliang Zhang; Hongmei Sun; Zhaofeng Niu; Hong Zong; Aimin Zang; Xinshuai Wang; Xinyu Qian; Shikai Wu; Jianyun Nie; Lijia He; Ying Cheng; Yanrong Hao; Yi Zhai; Huiping Li; Jingfen Wang; Shihong Wei; Man Li; Yunjiang Liu; Hongqiang Guo; Qun Hu; Lina Liu; Xinghua Han; Ruizhen Luo; Mingli Ni; Xianjun Tang; Zhenhua Zhai; Meiqian Ding; Haibo Wang; Peng Shen; Xian Wang; Lian Liu; Wenyan Chen; Gang Liu; Zhengwen Cai; Zefei Jiang
Safety and tolerability of bireociclib for the treatment of advanced solid tumors as monotherapy and in combination with endocrine therapy: a multicenter, open-label, phase 1 clinical trial

比卡鲁胺单药治疗及联合内分泌疗法治疗晚期实体瘤的安全性和耐受性：一项多中心、开放标签、I期临床试验

BMC Medicine
IF8.3
2025-10-100
OAAI
Jiayu Wang; Tao Sun; Zhongsheng Tong; Xichun Hu; Wei Li; Min Yan; Yunjiang Liu; Quchang Ouyang; Xiaoqing Liu; Jian Fang; Huiping Li; Hui Li; Wenyan Chen; Chang Gong; Yuee Teng; Lingmei Xu; Xianghui Duan; Mingming Liu; Yaping Meng; Fei Liu; Li Wang; Binghe Xu
Phase 2 Study of the CDK4/6 Inhibitor FCN-437c in Combination With Fulvestrant or Letrozole and Goserelin in Patients With HR+, HER2-Advanced Breast Cancer
CANCER RESEARCH
IF16.6
2023-03-011
PRE
Shi, JiaJie; Li, Wei; Tong, Zhongsheng; Zang, Aimin; Zeng, Xiaohua; Wang, Shui; Huang, Tao; Wang, Ying; Song, Yanqiu; Kang, Lihua; Lv, Zheng; Shi, Yehui; Yang, Hua; Wu, Jing; Yin, Yongmei; Liang, Yan; Tan, Jie; Ming, Jie; Yang, Yaping; Luo, Simin; Gui, Xiujuan; Hui, Ai-Min; Wu, Zhuli; Tian, Ling; Yang, Yuchen; Diao, Lei; Zhang, Wenjing; Zhang, Yongjiao; Liu, Yunjiang
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2023-02-282
OAAI
Chen, Heyan; Maimaitiaili, Amina; Liu, Zhenzhen; Ling, Rui; Zhao, Yi; Yang, Hongjian; Liu, Yunjiang; Liu, Ke; Zhang, Jianguo; Mao, Dahua; Yu, Zhigang; Liu, Yinhua; Fu, Peifen; Wang, Jiandong; Jiang, Hongchuan; Zhao, Zuowei; Tian, Xingsong; Cao, Zhongwei; Wu, Kejin; Song, Ailin; Jin, Feng; He, Jianjun; Fan, Zhimin; Zhang, Huimin
Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial

pyrotinib、曲妥珠单抗和多西他赛新辅助治疗HER2-positive乳腺癌 (PHEDRA): 一项双盲、随机3期试验

BMC MEDICINE
IF8.3
2022-12-2748
OAAI
Wu, Jiong; Jiang, Zefei; Liu, Zhenzhen; Yang, Benlong; Yang, Hongjian; Tang, Jinhai; Wang, Kun; Liu, Yunjiang; Wang, Haibo; Fu, Peifen; Zhang, Shuqun; Liu, Qiang; Wang, Shusen; Huang, Jian; Wang, Chuan; Wang, Shu; Wang, Yongsheng; Zhen, Linlin; Zhu, Xiaoyu; Wu, Fei; Lin, Xiang; Zou, Jianjun

研究方向

暂未获取到该数据
张
张香美
H 指数:22论文数:129被引数:1,994
Z
Zefei Jiang
H 指数:46论文数:376被引数:1.5万
X
Xindi Ma
H 指数:8论文数:20被引数:242
P
Peifen Fu
H 指数:15论文数:48被引数:1,272
Y
Yongsheng Wang
H 指数:27论文数:172被引数:2,583
刘
刘强
H 指数:88论文数:942被引数:3.5万
S
Shusen Wang
H 指数:39论文数:237被引数:6,448
刘真真 封面图
刘真真
H 指数:43论文数:474被引数:6,674
S
Shang Wu
H 指数:5论文数:15被引数:152
J
Jinhai Tang
H 指数:60论文数:374被引数:1.1万